A plausible explanation could be a reorientation of Lys105 towards GS resulting in a decreased stabilization of the active site thiolate as a leaving group
Skin photos, hair density, recovery quality these are easier to evaluate when you step back from active use and observe what persists
Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD
Unlike most peptides on the FDA's review schedule, GHK-Cu (copper peptide) has a split regulatory path: non-injectable routes are being removed from Category 1, while injectable routes are being removed from Category 2 and both are heading to Pharmacy Compounding Advisory Committee (PCAC) review before February 2027
Whether youre looking to smooth acne scars, reduce the appearance of stretch marks, or rejuvenate dull or damaged skin, each approach is scientifically grounded and biologically personalizednever one-size-fits-all